This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brito, V. N. Articles by Mendonca, B. B. Search for Related Content PubMed PubMed Citation Articles by Brito, V. N. Articles by Mendonca, B. B.

A Single Luteinizing Hormone Determination 2 Hours after Depot Leuprolide Is Useful for Therapy Monitoring of Gonadotropin-Dependent Precocious Puberty in Girls

Unidade de Endocrinologia do Desenvolvimento, Laboratório de Hormônios e Genética Molecular LIM/42, Disciplina de Endocrinologia, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, 05403-900 Sao Paulo, Brazil

Address all correspondence and requests for reprints to: Dr. Vinicius N. Brito, Hospital das Clínicas Faculdade de Medicina da Universidade de São Paulo, Disciplina de Endocrinologia e Metabologia, Avenue Dr. Eneas de Carvalho Aguiar, 155 2°andar Bloco 6, 05403900, Sao Paulo SP, Brazil. E-mail: vinbrito{at}uol.com.br or beremen{at}usp.br.

Long-acting GnRH analogs represent the standard treatment for gonadotropin-dependent precocious puberty. The aim of this study was to determine the hormonal parameters for monitoring the adequacy of depot leuprolide acetate treatment in girls with clinical and hormonal diagnosis of gonadotropin-dependent precocious puberty. Eighteen girls were treated monthly with 3.75 mg depot leuprolide acetate. Adequate hypothalamic-pituitary-gonadal axis suppression during treatment was achieved in 16 of the 18 girls according to the clinical parameters and prepubertal LH levels. In these 16 well-controlled girls, the LH peak after a classical GnRH test was compared with a single LH measurement obtained 2 h after depot leuprolide acetate administration before and during GnRH analog treatment. Before therapy, the mean ± SD LH peak after a classical GnRH test was 18.4 ± 11.2 IU/liter (ranging from 7–41.5 IU/liter), and it was 22.6 ± 8.3 IU/liter 2 h after the first depot leuprolide dose (ranging from 10–35.3 IU/liter). During therapy, the mean ± SD of LH peak after classical GnRH test was 1.4 ± 0.6 IU/liter (ranging from <0.6 to 2.3 IU/liter), and it was 2.7 ± 1.9 IU/liter (ranging from 0.7–6.6 IU/liter) 2 h after depot leuprolide. The LH peak after a classical GnRH test and that 2 h after depot leuprolide administration correlate significantly before and during treatment. In conclusion, we established the LH cut-off values for an adequate depot leuprolide therapy as an LH peak below 2.3 IU/liter after a classical GnRH test or below 6.6 IU/liter 2 h after depot leuprolide. The latter measurement may replace the classical GnRH test as a reliable and convenient tool for monitoring therapy in female gonadotropin-dependent precocious puberty.

This article has been cited by other articles:

				M. G. Teles, S. D.C. Bianco, V. N. Brito, E. B. Trarbach, W. Kuohung, S. Xu, S. B. Seminara, B. B. Mendonca, U. B. Kaiser, and A. C. Latronico A GPR54-Activating Mutation in a Patient with Central Precocious Puberty N. Engl. J. Med., February 14, 2008; 358(7): 709 - 715. [Abstract] [Full Text] [PDF]

				V. N. Brito, B. B. Mendonca, L. M. F. F. Guilhoto, K. C. M. Freitas, I. J. P. Arnhold, and A. C. Latronico Allelic Variants of the {gamma}-Aminobutyric Acid-A Receptor {alpha}1-Subunit Gene (GABRA1) Are Not Associated with Idiopathic Gonadotropin-Dependent Precocious Puberty in Girls with and without Electroencephalographic Abnormalities J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2432 - 2436. [Abstract] [Full Text] [PDF]

				A. Badaru, D. M. Wilson, L. K. Bachrach, P. Fechner, L. M. Gandrud, E. Durham, K. Wintergerst, C. Chi, K. O. Klein, and E. K. Neely Sequential Comparisons of One-Month and Three-Month Depot Leuprolide Regimens in Central Precocious Puberty J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1862 - 1867. [Abstract] [Full Text] [PDF]